Hacker News Reader

BigPharma and others will gladly take care of the research debt, and they'll be paid handsomely. They seem pretty enthusiastic about it:

https://www.science.org/content/blog-post/pharma-ceos-speaki...

View on HN

The research done at universities and pharma companies is simply different and not interchangeable. This move will also kill the pipeline for new scientists that pharma companies want to hire.

If you want to read a bit about all these event from the perspective of someone working in pharma I'd recommend Derek Lowe's blog:

https://www.science.org/blogs/pipeline

Reply on news.ycombinator.com